KAT2A anticorps (AA 411-837)
Aperçu rapide pour KAT2A anticorps (AA 411-837) (ABIN7596032)
Antigène
Voir toutes KAT2A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 411-837
-
Fonction
- Human KAT2A/GCN5 antibody
-
Purification
- Purified
-
Immunogène
- Recombinant human GCN5L2 (411-837aa) purified from E. coli
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing cycles
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- KAT2A (K(lysine) Acetyltransferase 2A (KAT2A))
-
Autre désignation
- KAT2A/GCN5
-
Sujet
- GCN5L2, as known as GCN5 and KAT2A is the use of immunoprecipitated GCN5L2 for acetylation toprovide the additional components important for acetylation. GCN5L2 can be one of the potential enzymesinvolved in acetylation in vivo. GCN5L2 is expressed predominantly in the embryo and newborn and is essentialfor normal embryonic development. Therefore, GCN5L2 appears to be important for differentiation ofembryonic-derived preadipocytes. On the one hand, loss of GCN5L2 leads to high incidence of apoptosis inthe GCN5L2 mutants that begins before the onset of morphological abnormality.
-
NCBI Accession
- NP_066564
-
Pathways
- Chromatin Binding, Tube Formation
Antigène
-